about

allu exists to make the next generation of therapeutics available to patients in Australasia and beyond – with a focus on the evolving psychedelic and peptide spaces.

Spun out of New Zealand’s largest medicinal cannabis distributor, NUBU, by Founder/CEO, Mark Dye, allu has over a decades experience in the unregistered therapeutics space.

Got a question?

Feel free to drop us an email info@allutherapeutics.com , via the contact form here, or via LinkedIn.